Multivariate survival analysis also indicated IQGAP3 expression was indeed an independent prognostic factor for OS and progression-free survival (PFS; p = 0.003 and p = 0.001, respectively; Table 2) in the whole cohort breast cancer patients (n = 257). This evidence concerns the gene IQGAP3 and breast cancer.